514 related articles for article (PubMed ID: 31286573)
1. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
4. Materializing Personalized Medicine.
Artzi N
Adv Mater; 2020 Apr; 32(13):e1908065. PubMed ID: 32237118
[No Abstract] [Full Text] [Related]
5. Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care.
Lin PC; Tsai YS; Yeh YM; Shen MR
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009026
[TBL] [Abstract][Full Text] [Related]
6. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy.
Bulashevska A; Nacsa Z; Lang F; Braun M; Machyna M; Diken M; Childs L; König R
Front Immunol; 2024; 15():1394003. PubMed ID: 38868767
[TBL] [Abstract][Full Text] [Related]
8. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.
Pinton P
Ann Med; 2023; 55(2):2300670. PubMed ID: 38163336
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
Sniecinski I; Seghatchian J
Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
[TBL] [Abstract][Full Text] [Related]
10. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
11. Theranostics and artificial intelligence: new frontiers in personalized medicine.
Belge Bilgin G; Bilgin C; Burkett BJ; Orme JJ; Childs DS; Thorpe MP; Halfdanarson TR; Johnson GB; Kendi AT; Sartor O
Theranostics; 2024; 14(6):2367-2378. PubMed ID: 38646652
[TBL] [Abstract][Full Text] [Related]
12. Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.
Duangrat R; Udomprasert A; Kangsamaksin T
Cancer Sci; 2020 Sep; 111(9):3164-3173. PubMed ID: 32589345
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology for the diagnosis and treatment of diseases.
Azzawi M; Seifalian A; Ahmed W
Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317
[No Abstract] [Full Text] [Related]
14. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
Rizzo LY; Theek B; Storm G; Kiessling F; Lammers T
Curr Opin Biotechnol; 2013 Dec; 24(6):1159-66. PubMed ID: 23578464
[TBL] [Abstract][Full Text] [Related]
18. Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory.
Ke W; Crist RM; Clogston JD; Stern ST; Dobrovolskaia MA; Grodzinski P; Jensen MA
Adv Drug Deliv Rev; 2022 Dec; 191():114591. PubMed ID: 36332724
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
20. Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery.
Nagarajan N; Yapp EKY; Le NQK; Kamaraj B; Al-Subaie AM; Yeh HY
Biomed Res Int; 2019; 2019():8427042. PubMed ID: 31886259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
